calendar: what's on?
- STS 20 Reunion
- STS Seminar: Collecting Minerals in the early Nineteenth Century: The Royal Institution and Humphry Davy
- STS Seminar: Framing problems of anatomical representations in 18thC Florence and 19thC Britain
- STS Seminar: Are Chemical Substances Natural Kinds?
- STS Seminar: Sketches of Another Future: Cybernetics in Britain, 1940-2000
- STS Seminar: Early Years of the Biological Weapons Convention
- STS Seminar: Sarah Edwards
- STS Seminar: Julie Anderson
- STS Seminar: Donald MacKenzie
- STS Seminar: Science and Diplomacy: Joseph Banks and the Macartney Embassy to China
- STS Seminar: Who studies mathematical practice and why
- PUS Seminar: Scidev.net and science journalism in South America
- PUS Seminar: 19thC public astronomy
- New book: Presocratics and the Supernatural
- Annual Grant Lecture
- Talk: Paul Robeson
- Life and Death Drawing: Expression
- Death by Hair: from Colonial South West Africa to Nazi Germany
- Film: When Worlds Collide (1951)
- Create a Wiser World
- Inaugural Lecture: Experimental State
- James Lovelock, Gaia, and science on a pagan planet
- TALK: Always looking at the stars...
- PUS Seminar: Toss Gascgoine
The Department of Science and Technology Studies, UCL is an interdisciplinary centre for the integrated study of science's history, philosophy, sociology, communication and policy, located in the heart of London. Founded in 1921. Award winning for teaching and research, plus for our public engagement programme. Rated as outstanding by students at every level.
At UCL, the academic mission is paramount. Our ambition is to achieve the highest standards in our teaching and research.
Join us for BSc, MSc, and PhD study.
Staff books include:
STS Seminar: Sarah Edwards
Publication date: Oct 2, 2013 4:16:47 PM
Jan 22, 2014 4:00:00 PM
End: Jan 22, 2014 6:00:00 PM
Location: South Wing, Garwood LT
Speaker: Dr Sarah Edwards, UCL
Title: The ethics of clinical research during a pandemic
Abstract: Clinical research under usual regulatory constraints may be difficult or even impossible in a public health emergency. Regulators must seek to strike a good balance between granting wide therapeutic access to new drugs and gathering sound evidence of safety and effectiveness at the same time. To inform policy, I re-examine the rationale for restricting new medicines to clinical trials, at any stage and for any population of patients, which resides in the precautionary principle, to show that its objective to protect public health, now or in the future, could soon be defeated in a pandemic. Providing wider therapeutic access and coordinating observations and natural experiments, including cluster trials where clusters are already confined, may provide such a balance. However, there are important questions of fairness to resolve before any such research can proceed.
Page last modified on 02 oct 13 16:16 by Jo E Pearson
UCL Department of Science and Technology Studies (STS)
0207 679 1328 office | +44 207 679 1328 international
firstname.lastname@example.org | www.ucl.ac.uk/sts | @stsucl
postal address: Gower Street, London, WC1E 6BT | United Kingdom
street address: 22 Gordon Square, London, WC1E 6BT | maps